Back to Search
Start Over
Circulating macrophage activation markers, CD163 and CD206, are associated with disease severity and treatment response in patients with autoimmune hepatitis:Circulating macrophage activation markers, CD163 and CD206, are associated with disease severity and treatment response in patients with autoimmune hepatitis
- Source :
- Grønbæk, H, Kazankov, K, Jessen, N, Sandahl, T D, Hamilton-Dutoit, S J, Vilstrup, H, Møller, H J, Kreutzfeldt, M & Møller, HJ 2014, ' Circulating macrophage activation markers, CD163 and CD206, are associated with disease severity and treatment response in patients with autoimmune hepatitis : Circulating macrophage activation markers, CD163 and CD206, are associated with disease severity and treatment response in patients with autoimmune hepatitis ', Hindsgavl Allé, 5500 Middelfart, Denmark, 05/09/2014-06/09/2014, .
- Publication Year :
- 2014
-
Abstract
- Circulating macrophage activation markers, CD163 and CD206, are associated with disease severity and treatment response in patients with autoimmune hepatitis
- Subjects :
- integumentary system
macromolecular substances
Subjects
Details
- Language :
- English
- Database :
- OpenAIRE
- Journal :
- Grønbæk, H, Kazankov, K, Jessen, N, Sandahl, T D, Hamilton-Dutoit, S J, Vilstrup, H, Møller, H J, Kreutzfeldt, M & Møller, HJ 2014, ' Circulating macrophage activation markers, CD163 and CD206, are associated with disease severity and treatment response in patients with autoimmune hepatitis : Circulating macrophage activation markers, CD163 and CD206, are associated with disease severity and treatment response in patients with autoimmune hepatitis ', Hindsgavl Allé, 5500 Middelfart, Denmark, 05/09/2014-06/09/2014, .
- Accession number :
- edsair.pure.au.......fac1e940b70e17bc3bdcd596efed29a0